Honey and Nigella Sativa in COVID-19 Prophylaxis
Overview
Honey and Nigella sativa has established antiviral, antibacterial, anti-inflammatory, and immunomodulatory roles. So it is planned to test for its prophylaxis
Full Title of Study: “Honey and Nigella Sativa in the Prophylaxis of COVID-19: A Randomized Controlled Trial”
Study Type
- Study Type: Interventional
- Study Design
- Allocation: Randomized
- Intervention Model: Parallel Assignment
- Primary Purpose: Prevention
- Masking: Triple (Care Provider, Investigator, Outcomes Assessor)
- Study Primary Completion Date: February 15, 2022
Interventions
- Drug: Honey
- 0.5 gm/Kg/day honey
- Drug: Nigella sativa seed
- 40 mg/Kg/day
- Other: Placebo
- empty capsule with sugar water
Arms, Groups and Cohorts
- Active Comparator: Honey and Nigella sativa Arm
- 0.5 g/kg/day honey 40 mg/Kg/day Nigella sativa seeds
- Placebo Comparator: Placebo Arm
- empty capsule with sugar water
Clinical Trial Outcome Measures
Primary Measures
- SARS-CoV-2 infection rate
- Time Frame: 14 days
- RT-PCR SARS-CoV-2
Participating in This Clinical Trial
Inclusion Criteria
- Health care professionals Post-exposure COVID-19 Exclusion Criteria:
- Multi-organ failure active COVID-19
Gender Eligibility: All
Minimum Age: 18 Years
Maximum Age: N/A
Are Healthy Volunteers Accepted: Accepts Healthy Volunteers
Investigator Details
- Lead Sponsor
- Sohaib Ashraf
- Provider of Information About this Clinical Study
- Sponsor-Investigator: Sohaib Ashraf, Registrar Cardiology – Sheikh Zayed Federal Postgraduate Medical Institute
- Overall Official(s)
- Sohaib Ashraf, MBBS, Study Director, Massachusetts General Hospital
- Muhammad Ashraf, PhD, Study Chair, University of Veterinary and Animal Sciences
- Ahmad Imran, MBBS, Principal Investigator, Shaikh Zayed Post-Graduate Medical Institute
- Moneeb Ashraf, MBBS, Principal Investigator, King Edward Medical University
- Overall Contact(s)
- Sohaib Ashraf, MBBS, 8573167995, sohaib@skzmdc.edu.pk
Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.